Skip to main content
Caplight Logo









Nervtex

Nervtex

Private
WuhanHealthcare & Life Scienceshttps://nervtex.com/

Last Round

VC Round

Jun 8, 2022

Company Overview

Nervtex operates in Healthcare & Life Sciences and is based in Wuhan. Its latest recorded funding round was a VC Round in June 2022.

Nervtex is a digital therapeutics company that develops AI and VR-based medical solutions for the management of neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Mental Health, Computer Vision, AR/VR Experiences, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nervtex Comparables

Compare Nervtex with similar companies based on industry and business-model similarity.

Nervtex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Digital Gait Labs
78%
Rune Labs
78%
neuroClues
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nervtex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 8, 2022
AngelJul 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Nervtex Investors

Notable investors and investment history

Nervtex investors
InvestorRounds
YuanBio Venture CapitalAngel
Yuanhe OriginVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2022

    Funding round led by Yuanhe Origin.

  • Jul 1, 2021

    Led by YuanBio Venture Capital

Book a demo to see all signals

For institutional investors. Book with your work email.

Nervtex Filings

Explore SEC and related filing metadata, where available.

Nervtex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nervtex's valuation, stock price, and market status.

Is Nervtex a public or private company?

Nervtex is a private company.

What is the current stock price of Nervtex?

Nervtex is a private company, so its shares have no public market price. Caplight tracks Nervtex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nervtex worth (valuation)?

Valuation information for Nervtex is not publicly available.

Can I buy Nervtex stock?

Nervtex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nervtex's last funding round?

Nervtex's most recent funding round was VC Round on June 8, 2022.

Who are the main investors in Nervtex?

Key investors in Nervtex include YuanBio Venture Capital, Yuanhe Origin.

Will Nervtex IPO soon?

No public IPO plans have been announced for Nervtex.

How can I track Nervtex secondary market activity?

Caplight tracks bids, offers, and trades in Nervtex's shares on secondary markets.

Firmographic Details

HeadquartersWuhan
Year Founded2018
Last FundingJun 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?